Table 3. Summary of patient samples in TCGA datasets.

The samples are classified by cutoffs on survival and relapse time based on the available clinical information in each dataset.

Cancer Type	Event	# of Patients by years
Ovarian serous cystadenocarcinoma(OV)	Survival	76(<3 ys) vs 62(>4 ys)
	Relapse	79(<1.5 ys) vs 68(>2 ys)
Breast invasive carcinoma(BRCA)	Survival	66(<5 ys) vs 57(>8 ys)
	Relapse	42(<5 ys) vs 38(>8 ys)
Lung adenocarcinoma(LUAD)	Survival	47(<2 ys) vs 56(>3 ys)
Lung squamous cell carcinoma(LUSC)	Survival	67(<2 ys)vs 77 (>3 ys)